Ascorbic acid Withdrawn Phase 2 Trials for Stage II Multiple Myeloma / Refractory Plasma Cell Neoplasm / Stage I Multiple Myeloma / Stage III Multiple Myeloma Treatment

WithdrawnTreatment2 IdentifierTitleDrugs
NCT00085345Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT00112879Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma